Edwin Moses
Chairman chez AVANTIUM N.V.
Fortune : 764 008 $ au 31/03/2024
Profil
Edwin Moses is currently the Chairman-Supervisory Board at Avantium NV since 2019.
He is also the Chairman at Achilles Therapeutics UK Ltd.
since 2018, LabGenius Ltd.
since 2020, Achilles Therapeutics Plc, Oak Hill Bio Corp.
since 2022, and Operating Partner at Keensight Capital SAS since 2020.
In his former roles, Dr. Moses served as the Chief Executive Officer & Director at Ablynx NV from 2014 to 2018.
He was also the Chairman at Capricorn Partners NV from 2009 to 2011, Galapagos Biotech Ltd.
from 2001 to 2006, and Oxford Asymmetry International Plc from 1993 to 2001.
Additionally, he held positions such as Non-Executive Chairman at Phoqus Pharmaceuticals Plc, ClinPhone Ltd., Noapab Holdings A, Paradigm Therapeutics Ltd.
from 2004 to 2007, Lectus Therapeutics Ltd., Pharmaceutical Profiles Group Ltd.
from 2005 to 2010, Proimmune Ltd., Sensorion SA from 2020 to 2021, and Evox Therapeutics Ltd.
from 2018 to 2020.
He also served as a Non-Executive Director at Fusion IP Ltd.
in 2009 and as a Director at Hammersmith Imanet Ltd.
from 1999 to 2000.
Dr. Moses was a Director at Evotec SE, Ionix Pharmaceuticals Ltd., Avantium Technologies BV, Oxford Drug Design Ltd.
from 2001 to 2002, The London Technology Network in 2002, ProPharma Ltd., Prolysis Ltd., Capricorn Health-Tech Fund NV from 2011 to 2016, European Biopharmaceutical Enterprises, AMS Biotechnology Ltd.
in 1993, and Principal at GE Healthcare Ltd.
(United Kingdom).
Dr. Moses obtained his undergraduate and doctorate degrees from The University of Sheffield.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AVANTIUM N.V.
0,25% | 10/05/2023 | 202 934 ( 0,25% ) | 462 446 $ | 31/03/2024 |
| 01/02/2023 | 241 250 ( 0,59% ) | 301 563 $ | 31/03/2024 |
Postes actifs de Edwin Moses
| Sociétés | Poste | Début |
|---|---|---|
| AVANTIUM N.V. | Chairman | 20/12/2019 |
| ACHILLES THERAPEUTICS PLC | Chairman | - |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Chairman | 10/12/2018 |
Labgenius Ltd.
 Labgenius Ltd. Pharmaceuticals: MajorHealth Technology Labgenius Ltd. discovers novel and optimized biological molecules using artificial intelligence, automation and synthetic DNA. It specializes in synthetic biology, DNA libraries, protein engineering, artificial intelligence and machine learning. The company was founded by James Field in 2012 and is headquartered in London, the United Kingdom. | Chairman | 20/04/2020 |
Keensight Capital SAS
 Keensight Capital SAS Investment ManagersFinance Keensight Capital SAS (Keensight) is an independent French venture capital firm which was established in 2001. Formerly known as R Capital Management SAS, a subsidiary of the Rothschild Group, the firm became independent in 2013 and changed their name to Keensight Capital. Keensight is located in Paris and manages venture capital investments, including the FCPR R Capital Technologies for a range of clients including European banks, pension schemes, insurance companies, government-controlled entities, fund of funds, family offices and high-net worth private individuals. | Private Equity Investor | 02/06/2020 |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Chairman | 12/04/2022 |
Anciens postes connus de Edwin Moses
| Sociétés | Poste | Fin |
|---|---|---|
| SENSORION | Chairman | 19/12/2021 |
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Chairman | 14/05/2020 |
| ABLYNX | Chief Executive Officer | 01/06/2018 |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Formation de Edwin Moses
| The University of Sheffield | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| EVOTEC SE | Health Technology |
| AVANTIUM N.V. | Producer Manufacturing |
| SENSORION | Health Technology |
| Entreprise privées | 31 |
|---|---|
Fusion IP Ltd.
 Fusion IP Ltd. Miscellaneous Commercial ServicesCommercial Services Fusion IP Ltd. operates as a holding company. It engages in the commercialization of intellectual properties that is developed at universities and similar establishments. The company was founded by Peter Leonard Grant, Stewart Gall and David Graham Baynes in 2002 and is headquartered in Sheffield, the United Kingdom. | Commercial Services |
Phoqus Pharmaceuticals Plc
 Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Health Technology |
Capricorn Partners NV
 Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium. | Finance |
| Hammersmith Imanet Ltd. | |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Oxford Asymmetry International Plc | Process Industries |
Ionix Pharmaceuticals Ltd.
 Ionix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ionix Pharmaceuticals Ltd. used to develop analgesic medicines for the treatment of acute and chronic pain. Its drugs were used for the treatment of pain associated with chronic debilitating diseases such as osteoarthritis, diabetes, cancer and multiple sclerosis. The company was founded by Andrew Sandham, Phillip J. Birch, John Wood and Ann Gail Hayes in 2001 and was located in Cambridge, UK. | Health Technology |
ClinPhone Ltd.
 ClinPhone Ltd. Medical/Nursing ServicesHealth Services ClinPhone Ltd. provides outsourcing services to pharmaceutical companies and new drugs testing services to clinical research organisations. Its telephone-based interactive voice-response system provides two-way communication between touch-tone telephones and complex, customised computer database applications. These applications allow rapid communication of data from doctors conducting clinical trials to company's pharmaceutical customers, enabling drugs to be brought to market more quickly. The company was founded in 1993 and is headquartered in Nottingham, UK with offices in the US, Belgium and Germany | Health Services |
Avantium Technologies BV
 Avantium Technologies BV Miscellaneous Commercial ServicesCommercial Services Avantium Technologies BV operates as chemical technology company. It offers a breeding ground for revolutionary renewable chemistry solutions. The firm specializes in innovations and technologies for catalytic research and development services and systems. The company was founded in February 2000 and is headquartered in Amsterdam, the Netherlands | Commercial Services |
| Noapab Holdings A/S | Commercial Services |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Health Technology |
Oxford Drug Design Ltd.
 Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Oxford Drug Design Ltd. develops application of new technologies to drive computer-aided drug discovery. It specializes in drug discovery, molecular modeling, lead identification and optimisation, formulation modeling and preclinical studies. The company was founded by W. Graham Richards in 2001 and is headquartered in Oxford, the United Kingdom. | Technology Services |
Paradigm Therapeutics Ltd.
 Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
Lectus Therapeutics Ltd.
 Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Lectus Therapeutics Ltd. Developed ion channel modulators and therapeutics. The company was founded in December 2002 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
The London Technology Network
 The London Technology Network Other Consumer ServicesConsumer Services The London Technology Network provides academic training in computer science, life science and physical science. It also offers technology consulting services to member companies. The company is headquartered in London, the United Kingdom. | Consumer Services |
Pharmaceutical Profiles Group Ltd.
 Pharmaceutical Profiles Group Ltd. Pharmaceuticals: MajorHealth Technology Pharmaceutical Profiles Ltd. develops drugs for pharmaceutical and biotech companies. The company studies how drugs are absorbed and processed in the human body. It utilizes gamma camera imaging products in its studies. It also provides complete scientific, regulatory and medical support for its client's clinical development programs. Pharmaceutical Profiles was founded in 1990 and is headquartered in Nottingham, UK. | Health Technology |
ClinPhone Plc
 ClinPhone Plc Packaged SoftwareTechnology Services The Group's principal activity is the provision of technology solutions to the clinical trials industry. The Group's technology, services and products provide its customers, typically pharmaceutical and biotechnology companies, collects data and arrange clinical trials. These includes a range of consultancy, services and software. The Group's products includes ClinPhone Patient Recruitment, ClinPhone Randomisation, ClinPhone Trial Supply Management, ClinPhone ePRO, ClinPhone Clinical Trials Management Software, ClinPhone Drug Accountability, ClinPhone Integration Services and ClinPhone Trial Supply Simulation. | Technology Services |
ProPharma Ltd.
 ProPharma Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, ProPharma Ltd. engages in pharmaceutical research and manufactures clinical trial supplies. The private company is based in Glasgow, UK. ProPharma was acquired by Evotec SE from University of Strathclyde on October 25, 2005. | Commercial Services |
Keensight Capital SAS
Keensight Capital SAS Investment ManagersFinance Keensight Capital SAS (Keensight) is an independent French venture capital firm which was established in 2001. Formerly known as R Capital Management SAS, a subsidiary of the Rothschild Group, the firm became independent in 2013 and changed their name to Keensight Capital. Keensight is located in Paris and manages venture capital investments, including the FCPR R Capital Technologies for a range of clients including European banks, pension schemes, insurance companies, government-controlled entities, fund of funds, family offices and high-net worth private individuals. | Finance |
Prolysis Ltd.
 Prolysis Ltd. Pharmaceuticals: MajorHealth Technology Prolysis Ltd. develops and manufactures pharmaceutical products. It develops antibacterial therapy to treat drug resistant infections. The company was founded in 1998 and is headquartered in Kidlington, UK. | Health Technology |
Proimmune Ltd.
 Proimmune Ltd. Pharmaceuticals: MajorHealth Technology Proimmune Ltd. develops, manufactures and distributes drugs. Its services include antigen characterization: T and B cell epitope discovery, immunogenicity risk management assays and cellular analysis services. The firm's products include pentamers, tetramers and monomers, CD1d tetramers, custom peptide products and antibodies. The company was founded by Linda Tan and Nikolai Schwabe in 2000 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Capricorn Health-Tech Fund NV
 Capricorn Health-Tech Fund NV Investment ManagersFinance Capricorn Health-Tech Fund NV invests in companies located in Western Europe. It targets companies operating in the fields of human health-technology. It provides financing for seed stage, early stage and growth stage in equity and debt with an investment size between EUR 0.5 million and EUR 6 million. It acquires mostly minority stakes but also majority stakes. | Finance |
European Biopharmaceutical Enterprises
 European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Health Technology |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Labgenius Ltd.
Labgenius Ltd. Pharmaceuticals: MajorHealth Technology Labgenius Ltd. discovers novel and optimized biological molecules using artificial intelligence, automation and synthetic DNA. It specializes in synthetic biology, DNA libraries, protein engineering, artificial intelligence and machine learning. The company was founded by James Field in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
Virion Biotherapeutics Ltd.
 Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Health Technology |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Health Technology |
| AMS Biotechnology Ltd. | |
| Achilles Therapeutics Plc | |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Commercial Services |
